Histone Methyltransferase (SUV39H1) Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-Histone Methyltransferase (SUV39H1) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHistone Methyltransferase (SUV39H1)
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat, Drosophila
Isotypen/a
Formataffinity purified
Size0.03 mg, 0.1 mg
Concentration0.5 mg/ml
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionBackground: The histone methyltransferase KMT1A / SUV39H1 is the mammalian homologue of the Drosophila PEV modifier Su(var)3-9 protein. SUV39H1 contains the SET and chromo domains. In eukaryotic cells, SUV39H1 and the methyl-lysine binding protein HP1 interact to repress transcription at heterochromatic sites. SUV39H1 methylates histone H3 on lysine 9, which generates a binding site for HP1 proteins that plays a role in heterochromatin formation and gene silencing.
ImmunogenImmunogen: Synthetic peptide surrounding amino acid 389 of mouse Histone Methyltransferase. Positive Control: 3T3 cell lysate
Other Names[Histone-lysine N-methyltransferase; SUV39H1; Histone H3-K9 methyltransferase 1; H3-K9-HMTase 1; Full=Position-effect variegation 3-9 homolog; Suppressor of variegation 3-9 homolog 1; Su(var)3-9 homolog 1], [Suv39h1; Suv39h1; mIS6; KMT1A; AI852103; AL022883; DXHXS7466e; H3-K9-HMTase 1; Suv39h; H3-K9-HMTase 1; Su(var)3-9 homolog 1]
Gene, Accession #Gene ID: 20937, NCBI: NP_035644.1
Catalog #MBS841013
Price$150, $290
Order / More InfoHistone Methyltransferase (SUV39H1) Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.